Accelerating a next generation of therapeutic innovation through consultancy, licensing, partnership & investment.
We offer:
A proven track record of senior scientific, technology and translational expertise in developmental and stem cell biology and application in biomedical discovery and therapy development supporting:
Technology & Market Assessment
Staff Training
Protocol & Assay Development
Product Discovery & Development
Facility Design & Qualification
Quality Assured Good Manufacturing Practice
Regulatory Authorisation
Company creation
A commercial licence to European Union Tissues and Cells Directive compliant human pluripotent stem cell lines for:
treatment of immune dysregulation & extracorporeal applications.
Sales and service of derivative products.
New intellectual property for control of cell specification and lead generation from unpublished cell RNAseq and secreted protein proteomic datasets.
Research grade working banks of 2 human pluripotent stem cell lines and differentiated primal cells